The Cannabinoid Journal

From containment to nurturing: How Outcome-Based Cooperative Regulation can support future growth of the UK’s legal cannabinoid sector

An Executive Summary of The Hodges Review

Jul 26, 2022 • Centre for Medicinal Cannabis

4

April 2022

Landmark day for UK CBD industry as FSA publishes long awaited list of products permitted for sale

The Food Standards Agency has published a list of the first CBD products available for sale in the UK, with more than 3,500 products making the cut.

Apr 5, 2022 • Centre for Medicinal Cannabis

2

March 2022

Episode 9: The importance of a new approach to cannabis

We explore the importance of the upcoming Hodges Review of UK Public Policy & Regulatory Stewardship of the Legal Cannabis Industry

Mar 28, 2022 • Centre for Medicinal Cannabis

2

19:59

The Hodges Review of UK Public Policy and Regulatory Stewardship of the Legal Cannabis Industry

A new wide ranging commission to review regulation and public policy relating to the UK’s legal cannabis industry.

Mar 23, 2022 • Centre for Medicinal Cannabis

2

Episode 8: The Decalogue Review

Listen now | We hear from the authors of our recent Decalogue paper, hosted by Róisín Delaney

Mar 2, 2022 • Centre for Medicinal Cannabis

1

38:39

February 2022

10. Reforming the Proceeds of Crime of Act

Our final paper in the Decalogue abstract series is written by Dylan Kennett, Senior Associate at DLA Piper

Feb 2, 2022 • Centre for Medicinal Cannabis

12

9. Germany | Europe’s Cannabis Frontier

Is Germany fast becoming Europe’s cannabis frontier? Alfredo Pascual, an Investment Analyst with Seed Innovations explores exactly this in our ninth…

Feb 1, 2022 • Centre for Medicinal Cannabis

32

1

January 2022

8. Policing illicit medicinal cannabis

Our eighth paper for Decalogue is written by cannabis campaigner, advocate and patient Carly Barton.

Jan 31, 2022 • Centre for Medicinal Cannabis

17

7. Can extending access to medicinal cannabis address health inequalities?

The seventh paper, is written by Dr Ayesha Mian. Dr Mian is a junior doctor working in the NHS and has a background in drug policy reform.

Jan 28, 2022 • Centre for Medicinal Cannabis

7

6. Equal Treatment | CBMP’s & Specials

The sixth paper from ten in our Decalogue pamphlet comes from Jonathan Hodgson, CEO of Rokshaw Laboratories & Pierre van Weperen, MD at Grow Group

Jan 27, 2022 • Centre for Medicinal Cannabis

16

4

5. A Risk-based Approach to Cannabis

A Risk-based Approach to Cannabis was written by Hari Guliani, the Head of Columbia Care International

Jan 26, 2022 • Centre for Medicinal Cannabis

13

1

10 Years On: What we Achieved in Medicinal Cannabis

The fourth paper in our Decalogue series is written by Pierre van Weperen, MD of Grow Group

Jan 25, 2022 • Centre for Medicinal Cannabis

21

2